topicProbiotics Migraine Meta-Analysis
claimMigraine is a primary headache disorder affecting about 14% of the global population.
evidence level1
citationGrodzka O (2025)
sourceGut microbiota, probiotics, and migraine: a clinical review and meta-analysis.
topicProbiotics Migraine Meta-Analysis
claimThe knowledge about migraine pathophysiology is increasing constantly; however, there are still many unknowns and uncertainties.
evidence level1
citationGrodzka O (2025)
sourceGut microbiota, probiotics, and migraine: a clinical review and meta-analysis.
topicProbiotics Migraine Meta-Analysis
claimIn addition to its high prevalence and disability burden, migraine is associated with substantial socioeconomic costs, with estimated direct and indirect expenditures of approximately USD 36 billion annually in the United States [].
evidence level3
citationKozák Márk (2026)
sourceMigraine and the Gut–Brain Axis—The Role of Microbiome-Targeted Biotics
topicProbiotics Migraine Meta-Analysis
claimClinically, migraine is characterized by recurrent attacks of moderate-to-severe headache lasting 4–72 h, typically unilateral and pulsating, aggravated by routine physical activity, and frequently accompanied by photophobia and phonophobia; in a substantial subset of patients, attacks are associated with reversible focal neurological symptoms called aura.
evidence level3
citationKozák Márk (2026)
sourceMigraine and the Gut–Brain Axis—The Role of Microbiome-Targeted Biotics
topicProbiotics Migraine Meta-Analysis
claim6 7 8 9 10 11 12 2 13 14 10 15 16 Helicobacter pylori The most common gastrointestinal disorders associated with migraine are irritable bowel syndrome (IBS) (reported in up to 50% of patients with migraine []), inflammatory bowel disease (IBD) [,,], gastroesophageal reflux disease (GERD) [], functional dyspepsia [,], cyclic vomiting syndrome [], peptic ulcers andinfections [,].
evidence level3
citationKozák Márk (2026)
sourceMigraine and the Gut–Brain Axis—The Role of Microbiome-Targeted Biotics
topicProbiotics Migraine Meta-Analysis
claim1 2 3 4 2 3 5 Migraine is a prevalent primary headache disorder with significant morbidity and rising prevalence, affecting around 14% of the global population [].
evidence level3
citationKozák Márk (2026)
sourceMigraine and the Gut–Brain Axis—The Role of Microbiome-Targeted Biotics